At a time when many medtech companies are struggling, DexCom, Inc.’s CEO and president Kevin Sayer continues his laser-sharp focus to raise adoption by the diabetic community of the company’s innovative continuous glucose monitoring system (CGM).
This month alone, Dexcom announced it will make its flagship G6 CGM available at no cost to qualifying veterans through all US Department of Veterans Affairs Pharmacies, establish the first-ever registry to track outcomes of patients and health care professionals currently using the G6 in hospitals, announced plans to open a new office in
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?